Recall archive / FDA food enforcement
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. — FDA record F-0463-2024
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Sep 28, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
- Reason
- FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
- Classification
- Class III
- Recalling firm
- ActiPharma, Inc.
- Quantity
- 607 bottles of 100 tablets each
- Agency-reported status
- Terminated
- Source record identifier
- F-0463-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot 13309, Exp: 01/26 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Domestic distribution, in Puerto Rico.
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Nov 29, 2023
- Recall initiation date
- Sep 28, 2023
- Center classification date
- Nov 17, 2023
- Termination date
- Jan 16, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.